-460.30
(-0.62%)
-123.70
(-0.54%)
-497.09
(-2.64%)
GET IN TOUCH
SEBI presents Samajh Se Investing Simple:
RISK DISCLOSURES ON DERIVATIVES
|
Corporate News 22-Oct-2026 10:15 Concord Biotech to review Q2 financial results at board meeting on October 27, 2026 Concord Biotech Limited will hold a board meeting on Tuesday, October 27, 2026, to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026, along with a limited review report from its statutory auditors. The trading window for the company's securities will remain closed for 48 hours after the declaration of the financial results, as previously communicated in a letter dated September 28, 2026. |
INDIAN INDICES
73,249.39 -460.30 (-0.62%)
22,687.65 -123.70 (-0.54%)
GLOBAL INDICES
NA
22,919.11 -732.77(-3.10%)

